We use cookies to help provide you with the best possible online experience. Learn more

Press releases

Axim Nuclear & Oncology to supply RaySearch systems to South African radiotherapy market

RaySearch Laboratories AB (publ) shares news that Axim Nuclear & Oncology will be supplying treatment planning system RayStation®* to the radiotherapy market in South Africa.

Axim Nuclear & Oncology specializes in the sales and applications of nuclear medicine and radiation oncology products. The company currently supplies linear accelerators from Accuray, surface guided radiation therapy equipment from Vision RT, laser positioning equipment from LAP, medical physics QA from the Sun Nuclear Corporation and brachytherapy solutions from Xoft, a subsidiary of iCAD, Inc.

The South African market for treatment planning software is roughly split into privately-owned oncology practices as well as government-run oncology centers. The installed linear accelerator (LINAC) base of more than 80 linear accelerators are predominantly from Elekta and Varian.

Johan Löf, founder and CEO, RaySearch, says: “As with any market expansion, reaching the South African market with our advanced treatment planning system RayStation is a milestone and a cause for optimism. Together with new distributor agreements in North Africa and South America, RaySearch software is becoming available to many more medical professionals each year.”


About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide. 


* Subject to regulatory clearance in some markets.

More information about RaySearch is available at www.raysearchlabs.com

For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00

Peter Thysell, CFO, RaySearch Laboratories AB (publ) 
Telephone: +46 (0)70 661 05 59